These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 18439941
1. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Kleinberg L, Holth A, Trope CG, Reich R, Davidson B. Hum Pathol; 2008 May; 39(5):747-57. PubMed ID: 18439941 [Abstract] [Full Text] [Related]
2. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma. Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B. Cancer; 2007 Jan 15; 109(2):228-38. PubMed ID: 17167759 [Abstract] [Full Text] [Related]
3. Expression and clinical role of antiapoptotic proteins of the bag, heat shock, and Bcl-2 families in effusions, primary tumors, and solid metastases in ovarian carcinoma. Elstrand MB, Kleinberg L, Kohn EC, Tropé CG, Davidson B. Int J Gynecol Pathol; 2009 May 15; 28(3):211-21. PubMed ID: 19620938 [Abstract] [Full Text] [Related]
4. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival. Davidson B, Hadar R, Stavnes HT, Trope' CG, Reich R. Hum Pathol; 2009 May 15; 40(5):705-13. PubMed ID: 19157507 [Abstract] [Full Text] [Related]
5. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma. Kleinberg L, Dong HP, Holth A, Risberg B, Trope' CG, Nesland JM, Flørenes VA, Davidson B. Hum Pathol; 2009 Jun 15; 40(6):795-806. PubMed ID: 19157506 [Abstract] [Full Text] [Related]
6. The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma. Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R. Gynecol Oncol; 2006 Dec 15; 103(3):831-40. PubMed ID: 16919315 [Abstract] [Full Text] [Related]
7. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells. Davidson B, Baekelandt M, Shih IeM. Diagn Cytopathol; 2007 Dec 15; 35(12):756-60. PubMed ID: 18008338 [Abstract] [Full Text] [Related]
8. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance. Hetland TE, Hellesylt E, Flørenes VA, Tropé C, Davidson B, Kærn J. Hum Pathol; 2011 Jul 15; 42(7):1019-26. PubMed ID: 21315408 [Abstract] [Full Text] [Related]
9. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma. Davidson B, Shih IeM, Wang TL. Hum Pathol; 2008 Nov 15; 39(11):1630-6. PubMed ID: 18656238 [Abstract] [Full Text] [Related]
10. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study. Davidson B, Gotlieb WH, Ben-Baruch G, Kopolovic J, Goldberg I, Nesland JM, Berner A, Bjåmer A, Bryne M. Gynecol Oncol; 2000 Apr 15; 77(1):35-43. PubMed ID: 10739688 [Abstract] [Full Text] [Related]
11. Angiogenic molecule expression is downregulated in effusions from breast cancer patients. Konstantinovsky S, Nielsen S, Vyberg M, Kvalheim G, Nesland JM, Reich R, Davidson B. Breast Cancer Res Treat; 2005 Nov 15; 94(1):71-80. PubMed ID: 16142438 [Abstract] [Full Text] [Related]
12. Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors. Kleinberg L, Pradhan M, Tropé CG, Nesland JM, Davidson B, Risberg B. Diagn Cytopathol; 2008 Sep 15; 36(9):637-44. PubMed ID: 18677760 [Abstract] [Full Text] [Related]
13. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions. Slipicevic A, Øy GF, Askildt IC, Holth A, Hellesylt E, Flørenes VA, Davidson B. Hum Pathol; 2009 Apr 15; 40(4):527-37. PubMed ID: 19121847 [Abstract] [Full Text] [Related]
14. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma. Davidson B, Shafat I, Risberg B, Ilan N, Trope' CG, Vlodavsky I, Reich R. Gynecol Oncol; 2007 Feb 15; 104(2):311-9. PubMed ID: 17030350 [Abstract] [Full Text] [Related]
16. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Davidson B, Elstrand MB, McMaster MT, Berner A, Kurman RJ, Risberg B, Trope CG, Shih IeM. Gynecol Oncol; 2005 Jan 15; 96(1):42-7. PubMed ID: 15589578 [Abstract] [Full Text] [Related]
17. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions. Kleinberg L, Flørenes VA, Nesland JM, Davidson B. Am J Clin Pathol; 2007 Sep 15; 128(3):389-97. PubMed ID: 17709312 [Abstract] [Full Text] [Related]
18. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. Stavnes HT, Holth A, Don T, Kærn J, Vaksman O, Reich R, Trope' CG, Davidson B. Gynecol Oncol; 2013 May 15; 129(2):358-63. PubMed ID: 23438671 [Abstract] [Full Text] [Related]
19. The mitogen-activated protein kinases (MAPK) p38 and JNK are markers of tumor progression in breast carcinoma. Davidson B, Konstantinovsky S, Kleinberg L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM, Reich R. Gynecol Oncol; 2006 Sep 15; 102(3):453-61. PubMed ID: 16494928 [Abstract] [Full Text] [Related]
20. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions. Bock AJ, Nymoen DA, Brenne K, Kærn J, Davidson B. Hum Pathol; 2012 May 15; 43(5):669-74. PubMed ID: 21855113 [Abstract] [Full Text] [Related] Page: [Next] [New Search]